Eugenio Galli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

InflaMix Predicts Severe CRS, ICU Admission, and Progression-Free Survival After CAR-T Therapy in LBCL.

InflaMix Predicts Severe CRS, ICU Admission, and Progression-Free Survival After CAR-T Therapy in LBCL.

Journal: European journal of haematology

Published: July 24, 2026

Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.

Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.

Journal: EULAR rheumatology open

Published: June 29, 2026

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Journal: Haematologica

Published: June 02, 2026

Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis.

Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis.

Journal: Bone marrow transplantation

Published: May 20, 2026

Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis.

Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis.

Journal: Bone marrow transplantation

Published: April 21, 2026

Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling.

Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling.

Journal: Annals of hematology

Published: February 23, 2026

Beyond comorbidities: CAR-T as a safe and effective option in frail patients with second-line DLBCL

Beyond comorbidities: CAR-T as a safe and effective option in frail patients with second-line DLBCL

Journal: Recenti progressi in medicina

Published: February 20, 2026

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation.

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation.

Journal: EClinicalMedicine

Published: February 04, 2026

Lymphodepletion and donor lymphocyte infusions (LD-DLI) for DLI-non responsive myelofibrosis.

Lymphodepletion and donor lymphocyte infusions (LD-DLI) for DLI-non responsive myelofibrosis.

Journal: Bone marrow transplantation

Published: January 14, 2026

Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting.

Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting.

Journal: Mediterranean journal of hematology and infectious diseases

Published: November 27, 2025

Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells.

Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells.

Journal: Clinical and experimental medicine

Published: November 20, 2025

Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

Journal: Blood advances

Published: October 20, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026